Mark Morais serves as the Chief Operating Officer and President of Clinical Services at Fortrea Holdings Inc., a leading provider of clinical trial solutions to the life sciences industry. With over two decades of experience in the pharmaceutical and healthcare sectors, Morais has a proven track record of driving operational excellence and strategic growth. Prior to joining Fortrea, he held various leadership positions at major companies, including LabCorp, where he served as the Executive Vice President and Chief Operating Officer of the Drug Development business. His extensive background in clinical research and operations has been instrumental in shaping Fortrea's approach to delivering innovative and high-quality services to its clients. At Fortrea, Morais plays a pivotal role in overseeing the company's clinical services division, which is responsible for managing and executing clinical trials across various therapeutic areas. His leadership has been crucial in enhancing the company's capabilities in patient recruitment, site management, and data analytics, ultimately improving the efficiency and success rates of clinical trials. Under his guidance, Fortrea has expanded its global footprint and strengthened its partnerships with pharmaceutical and biotech companies, positioning the company as a trusted partner in the drug development process. Morais's achievements extend beyond his current role at Fortrea. He has been recognized for his contributions to the industry, receiving accolades for his leadership in driving innovation and operational improvements. Morais holds a Bachelor of Science degree in Biology from the University of Massachusetts Amherst and an MBA from Northeastern University. His commitment to advancing healthcare through clinical research continues to drive his work at Fortrea, where he remains focused on delivering solutions that accelerate the development of life-changing therapies.